{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"title":"Complete Response (CR)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"title":"Partial Response (PR)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"}]}],"title":"Non-responder (NR)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}],"title":"Progressive Disease (PD)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"}],"units":"Participants"}],"description":"The following criteria is used to determine response to GVHD treatment. Complete response (CR) is complete resolution of all clinical signs and symptoms of acute GVHD. Partial response (PR) is 50% reduction in skin rash, stool volume or frequency, and/or total bilirubin. Failure to maintain adequate performance status (Karnofsky Score \\>/= 70%). Non-responder (NR) \\<50% reduction in skin rash, stool volume or frequency, and/or total bilirubin. Failure to maintain adequate performance status (Karnofsky Score \\</= 70%). Progressive disease (PD) is further progression of signs and symptoms of acute GVHD, and/or decline in performance status after the initiation of therapy.","groups":[{"description":"Subjects will receive a unmanipulated donor lymphocyte infusion (DLI) on Day 1 after radiation (single, 8-Gy fraction to the maximum number of lesions).","id":"OG000","title":"Donor Lymphocyte Infusion/Radiation"},{"description":"Subjects will receive radiation (single, 8-Gy fraction to the maximum number of lesions).","id":"OG001","title":"Radiation/No Donor Lymphocyte Infusion"},{"description":"Subjects will receive a unmanipulated donor lymphocyte infusion (DLI) on Day 0.","id":"OG002","title":"Donor Lymphocyte Infusion-Control"}],"paramType":"NUMBER","populationDescription":"No results were collected on the Donor Lymphocyte Infusion-Donor \"Arm\". This arm allowed for collection of the lymphocytes on healthy donors for infusion on the DLI/Radiation Arm or the DLI/Control Group.","reportingStatus":"POSTED","timeFrame":"Up to 100 days","title":"Response to Graft Versus Host Disease (GVHD) Treatment","type":"PRIMARY","unitOfMeasure":"participants"}